SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-004174
Filing Date
2024-03-28
Accepted
2024-03-28 09:06:38
Documents
15
Period of Report
2024-03-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agrx-20240328x8k.htm   iXBRL 8-K 37758
2 EX-99.1 agrx-20240328xex99d1.htm EX-99.1 315187
3 GRAPHIC agrx-20240328xex99d1001.jpg GRAPHIC 2988
  Complete submission text file 0001558370-24-004174.txt   503162

Data Files

Seq Description Document Type Size
4 EX-101.SCH agrx-20240328.xsd EX-101.SCH 3437
5 EX-101.LAB agrx-20240328_lab.xml EX-101.LAB 15928
6 EX-101.PRE agrx-20240328_pre.xml EX-101.PRE 10132
19 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20240328x8k_htm.xml XML 4819
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36464 | Film No.: 24793904
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)